Annexon, Inc. (ANNX) intrinsic value & 10-year financials

Annexon, Inc. (ANNX) has no Graham intrinsic value right now because the formula needs positive earnings.

Graham intrinsic value
—
Share price (Oct 17, 2026)
$3.41
Market cap
$528.9M
Revenue (FY2025)
—
ROIC (10-yr avg)
-79.6%
Free cash flow (FY2025)
-$186.5M

ANNX 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 — -$206.7M -$1.34 -$186.5M — -126.2%
FY2024 — -$138.2M -$1.01 -$118.0M — -94.9%
FY2023 — -$134.2M -$1.77 -$121.3M — -162.1%
FY2022 — -$141.9M -$2.60 -$122.8M — -93.0%
FY2021 — -$130.3M -$3.40 -$107.8M — -68.4%
FY2020 — -$63.4M — -$53.6M — -52.0%
FY2019 — -$37.2M — -$28.6M — 39.5%
FY2018 — — — — — —

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

Annexon, Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.

Annexon, Inc. has historically struggled to out-earn its cost of capital, averaging just -56.7% ROIC.

Annexon, Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.

Benjamin Graham lens

Annexon, Inc. is evaluated under Benjamin Graham's defensive framework using SEC EDGAR fundamentals using an 8.5 + 2g earnings multiple and a 5.1% AAA bond-yield baseline.

ANNX stock: frequently asked questions

What is the intrinsic value of Annexon, Inc. (ANNX) stock?

Graham's formula only works with positive earnings. Annexon, Inc. reported diluted EPS of -$1.34 in fiscal 2025, so no Graham value is shown. The 10-year table shows revenue and cash-flow trends instead.

Does Annexon, Inc. generate free cash flow?

Annexon, Inc. generated -$186.5M of free cash flow (operating cash flow minus capital expenditures) in fiscal 2025. Free cash flow was positive in 0 of the last 7 reported years.

What is ANNX's return on invested capital?

Average ROIC over the last 8 fiscal years was -79.6%, and average return on equity was -43.1%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this ANNX data come from?

From Annexon, Inc.'s annual 10-K filings on SEC EDGAR, most recently filed May 7, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar pharmaceutical preparations stocks